MeiraGTx Holdings plc

MGTXReported to SECin USCIK 0001735438Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at MeiraGTx Holdings plc, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
SEBULSKY ALAN—Awardnothing paid100,000 sharesSep 24, 2026SEBULSKY ALANnothing paidAward · Sep 24Award100,000Sep 24, 2026
Forbes AlexandriaPRESIDENT & CEOOpen-market sell$859,32062,000 sharesAug 18, 2026Forbes AlexandriaPRESIDENT & CEO$859,320Sell · Aug 18Open-market sell62,000Aug 18, 2026
Giroux RichardCFO & COOOpen-market sell$700,56056,000 sharesJul 21, 2026Giroux RichardCFO & COO$700,560Sell · Jul 21Open-market sell56,000Jul 21, 2026
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGYOpen-market sell$374,16925,112 sharesJul 7, 2026Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY$374,169Sell · Jul 7Open-market sell25,112Jul 7, 2026
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGYOpen-market sell$35,3012,547 sharesJul 7, 2026Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY$35,301Sell · Jul 7Open-market sell2,547Jul 7, 2026